Design of translactam HCMV protease inhibitors as potent antivirals.
about
Current and potential treatments for ubiquitous but neglected herpesvirus infectionsEnzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric ProteasePalladium(II)-catalyzed enantio- and diastereoselective synthesis of pyrrolidine derivativesAnti-herpesvirus agents: a patent and literature review (2003 to present).KSHV targeted therapy: an update on inhibitors of viral lytic replication.5'-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine.Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format.Integration of electrooxidative cyclization and chemical oxidation via alkoxysulfonium ions. Synthesis of exocyclic ketones from alkenes with cyclization.
P2860
Q27023452-48402F6E-86C0-423F-8BA9-8AFC16D36B2EQ35785306-FE1C20C4-0ECB-4752-AF3B-73EC7DB43C44Q35907685-C6F6355A-7339-45C2-9476-A31A3B0D76D1Q36282903-0421D451-C684-476E-99A3-61A9521BABD8Q38228015-7383D11A-93AF-4C06-8E63-26F372AB31E7Q38271135-54CC87DF-2D70-43AC-A33D-E920445C360EQ39899952-BFD5AD4A-C738-4742-93BF-30D77E77BC49Q43105250-14EC939C-1D61-47F8-9FE9-71BC047E9B42Q45893143-AB08B3D8-D0D0-43BE-B952-AEEE4F1DE72E
P2860
Design of translactam HCMV protease inhibitors as potent antivirals.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Design of translactam HCMV protease inhibitors as potent antivirals.
@ast
Design of translactam HCMV protease inhibitors as potent antivirals.
@en
type
label
Design of translactam HCMV protease inhibitors as potent antivirals.
@ast
Design of translactam HCMV protease inhibitors as potent antivirals.
@en
prefLabel
Design of translactam HCMV protease inhibitors as potent antivirals.
@ast
Design of translactam HCMV protease inhibitors as potent antivirals.
@en
P356
P1476
Design of translactam HCMV protease inhibitors as potent antivirals.
@en
P2093
Alan D Borthwick
P304
P356
10.1002/MED.20030
P577
2005-07-01T00:00:00Z